Spotlight on Cannara Biotech with Nicholas Sosiak
In this episode, David Flores sits down with Cannara CFO Nicholas Sosiak to discuss the Company's goals for the future and spotlight what differentiates Cannara from other companies in the cannabis space.
Psychedelic Spotlight Podcast · Nicholas Sosiak, David Flores
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Cannara Biotech is a Canadian cannabis company located in Quebec. Delivering a premium quality product at an accessible price is at the heart of their ethos. This principle has guided them since from the onset, and has allowed their company to emerge as one of Quebec's fast-growing licensed producers.
They are committed to delivering exceptional product quality and strive for operational excellence. Their cannabis is grown in state-of-the-art facilities, employing methods used in the most sophisticated markets in the world; cultivated from rare genetics, hang dried, slow cured, and hand trimmed.
Today, Cannara is recognized for its craft quality at disruptive pricing, and has rapidly carved out market share in Quebec.
You can learn more at their website: https://www.cannara.ca/en/